Can vonoprazan (Voquezna) be used in a patient with stage 4 chronic kidney disease (eGFR 15–29 mL/min/1.73 m²)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Take Voquezna with Stage 4 CKD?

Yes, vonoprazan (Voquezna) can be used in stage 4 CKD, but requires dose reduction to 10 mg once daily for healing erosive esophagitis, while maintenance therapy and heartburn relief use standard dosing. 1

Dose Adjustments by Indication

Healing of Erosive Esophagitis

  • Reduce dose to 10 mg once daily when eGFR is less than 30 mL/min/1.73 m² (stage 4 CKD) 1
  • Standard 20 mg once daily dosing applies only when eGFR is 30 mL/min or greater 1

Maintenance Therapy and Heartburn Relief

  • No dose adjustment required for maintenance of healed erosive esophagitis or relief of heartburn associated with non-erosive GERD, regardless of renal function 1
  • Use the same dosing as patients with normal renal function 1

H. pylori Treatment

  • Use is not recommended in stage 4 CKD (eGFR <30 mL/min/1.73 m²) for triple therapy regimens 1
  • This restriction likely relates to the concomitant antibiotics (amoxicillin and clarithromycin) rather than vonoprazan itself 1

Clinical Monitoring Considerations

Renal Function Surveillance

  • Monitor renal function every 3-6 months in stage 4 CKD patients, as recommended for this population 2
  • Reassess dosing if eGFR changes significantly, particularly if it improves above 30 mL/min/1.73 m² or declines to stage 5 1

Safety Monitoring

  • Watch for acute tubulointerstitial nephritis, which has been reported with vonoprazan and requires discontinuation if suspected 1
  • Monitor for signs of Clostridioides difficile-associated diarrhea, as acid suppression may increase risk 1
  • Use the shortest duration appropriate to the condition being treated 1

Important Caveats

Drug Interactions in CKD

  • Stage 4 CKD patients are at higher risk for drug-drug interactions due to altered pharmacokinetics 3, 4
  • Vonoprazan is contraindicated with rilpivirine-containing products regardless of renal function 1

Long-term Considerations

  • Prolonged acid suppression can lead to vitamin B12 deficiency and hypomagnesemia, which may be more problematic in advanced CKD 1
  • Consider periodic monitoring of vitamin B12 and magnesium levels in patients requiring long-term therapy 1

Practical Implementation

  • Swallow tablets whole; do not crush or chew 1
  • Can be taken with or without food 1
  • If a dose is missed for healing/maintenance indications, take within 12 hours; otherwise skip and resume regular schedule 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2021

Related Questions

What are the guidelines for using pantoprazole (Proton Pump Inhibitor) in patients with Chronic Kidney Disease (CKD)?
What is the recommended dosing adjustment for Abilify (aripiprazole) in patients with impaired renal function?
How should the dose of Acyclovir (antiviral medication) be adjusted in a patient with impaired renal function?
What is the recommended dose adjustment of Acyclovir (antiviral medication) for a patient with stage 3 Chronic Kidney Disease (CKD) and impaired renal function?
What is the appropriate treatment and dosage for an 84-year-old patient with a urinary tract infection (UTI), chronic kidney disease (CKD) stage 5, and an extensive cardiac history, who is prescribed Cipro (ciprofloxacin) and fluoxetine?
In a high‑risk patient with bicuspid severe aortic stenosis awaiting transcatheter aortic valve replacement, can balloon aortic valvuloplasty be used as a temporary bridge, and what are the recommended technique, timing, and antiplatelet regimen?
Can Xolair (omalizumab) be used to treat moderate‑to‑severe allergic asthma, chronic spontaneous urticaria, or IgE‑mediated food allergy, and what are the appropriate dosing, monitoring requirements, and alternative therapies?
How do I determine if a gastrointestinal stromal tumor is resectable?
What defines a genotype‑positive relative, is a karyotype required for their evaluation, and which provider orders and interprets the genetic testing?
With abdominal pain and a CT showing a 3.5 cm intramural uterine fibroid, physiologic cul‑de‑sac fluid, and a stable small fat‑containing umbilical hernia but no acute intra‑abdominal abnormality, what is the likely etiology and appropriate management?
What is the first-line disease-modifying antirheumatic drug for a 10-year-old with rheumatoid arthritis presenting with polyarthritis of small joints, fever, stiffness, and a rheumatoid factor of 100 U/mL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.